Reduction of melanogenic activity and responsiveness to α-melanocyte-stimulating hormone during serial passage of melanoma cells

Journal of Cutaneous Medicine and Surgery

Volumn 1, Issue 1, 1996, Pages 4-9

  Park, Hee Young ^a   Gilchrest, Barbara A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; ISOENZYME; MELANIN; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; HORMONE RESPONSE; MELANOGENESIS; MELANOMA CELL; MOUSE; NONHUMAN; PIGMENTATION; PRIORITY JOURNAL;

EID: 0030316816     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347549600100103     Document Type: Article

References (43)

1. Pawelek JM. Studies on the Cloudman melanoma cell line as a model for the action of MSH. Yale J Biol Med 1985; 58:571-578.
2. Pawelek JM, Wong G, Sansone M, Morowitz J. Molecular controls in mammalian pigmentation. Yale J Biol Med 1973; 46:430-443.
3. Pawelek JM. Factors regulating growth and pigmentation of melanoma cells. J Invest Dermatol 1976; 66:201-209.
4. Lerner AB, Fitzpatrick TB. Biochemistry of melanin formation. Physiol Rev 1950; 30:91-126.
5. Ito S. Biochemistry and physiology of melanin. In: Levine N, ed. Pigmentation and pigmentary disorders. Boca Raton, FL: CRC Press, 1993:33-59.
6. Jackson IJ. A cDNA encoding tyrosinase-related protein maps to the brown locus in mice. Proc Natl Acad Sci U S A 1988; 85:4392-4396.
7. Halaban R, Moellmann GE. Murine and human b locus pigmentation genes encode a glycoprotein (pg75) with catalase activity. Proc Natl Acad Sci U S A 1990; 87:4809-4813.
8. Vijayasaradhi S, Bouchard B, Houghton AN. The melanoma antigen pg75 is the human homologue of the mouse b (brown) locus gene product. J Exp Med 1990; 171:1375-1380.
9. Jackson IJ, Chambers DM, Tsukamoro K, et al. A second tyrosinase-related protein, TRP2, maps to and is mutated at the mouse slaty locus. EMBO J 1992; 11:527-535.
10. NIGMS human genetic mutant cell repository. Catalog of cell lines, 1993.
11. Park HY, Russakovsky V, Ohno S, Gilchrest BA. The β isoform of protein kinase C stimulates human melanogenesis by activating tyrosinase in pigment cells. J Biol Chem 1993; 268:11742-11749.
12. Gordon PR, Gilchrest BA. Human melanogenesis is stimulated by diacylglycerol. J Invest Dermatol 1989; 93:700-702.
13. Wade DR, Burkart ME. The role of adenosine 3′,5′-cyclic monophosphate in the density-dependent regulation of growth and tyrosinase activity of B-16 mouse melanoma cells. J Cell Physiol 1978; 94:265-274.
14. Fuller BB, Lunsford JB, Inman DS. α-Melanocyte-stimulating hormone regulation of tyrosinase in Cloudman S-91 mouse melanoma cell culture. J Biol Chem 1987; 262:4024-4033.
15. Korner A, Pawelek JM. Activation of melanoma tyrosinase by a cyclic AMP-dependent protein kinase in a cell-free system. Nature 1977; 267:444-447.
16. Halaban R, Pomerantz SH, Marshall S, Lerner AB. Tyrosinase activity and abundance in Cloudman melanoma cells. Arch Biochem Biophysiol 1984; 230:383-387.
17. Wong G, Pawelek JM. Melanocyte-stimulating hormone promotes activation of pre-existing tyrosinase molecules in Cloudman S91 cells. Nature 1975; 255:644-646.
18. Fuller BB, Viskochil DH. The role of RNA and protein synthesis in mediating the action of MSH on mouse melanoma cells. Life Sci 1979; 24:2404-2416.
19. Lotan R, Lotan D. Enhancement of melanotic expression in cultured mouse melanoma cells by retinoids. J Cell Physiol 1981; 106:179-189.
20. Imokawa G, Mishima Y. Loss of melanogenic properties in tyrosinase induced by glycosylation inhibitors within malignant melanoma cells. Cancer Res 1982; 42:1994-2002.
21. Varga JM, DiPasquale A, Pawelek J, et al. Regulation of melanocyte-stimulating hormone (MSH) action at the receptor level: discontinuous binding of MSH to synchronized melanoma cells during the cell cycle. Proc Natl Acad Sci U S A 1974; 71:1590-1593.
22. Lambert DT, Lerner AB. Optimization of a melanotropin-receptor binding assay using reversed high performance liquid chromatography. J Chromatog 1983; 226:567-576.
23. Park HY, Russakovsky V, Fernandez E, Gilchrest BA. Protein kinase C stimulates melanogenesis through phosphorylation of tyrosinase. J Invest Dermatol 1993; 100:37.
24. Park HY, Russakovsky V, Gilchrest BA. Depletion of protein kinase C blocks α-melanocyte stimulating hormone-induced melanogenesis. J Invest Dermatol 1992; 98:562.
25. Park HY, Russakovsky V, Fernandez E, Gilchrest BA. Pigmentation of S91 cells by α-melanocyte stimulating hormone requires protein kinase C-β mediated induction of tyrosinase. J Invest Dermatol 1994; 102:553.
26. Niles RM, Loewy BP. Induction of protein kinase C in mouse melanoma cells by retinoic acid. Cancer Res 1989; 49:4483-4487.
27. Gruber JR, Ohno S, Niles RM. Increased expression of protein kinase C-α plays a key role in retinoic acid-induced melanoma differentiation. J Biol Chem 1992; 267:13356-13360.
28. Fuller BB, Niekrasz I, Hoganson GE. Down-regulation of tyrosinase mRNA levels in melanoma cells by tumor promoters and by insulin. Mol Cell Endocrinol 1990; 72:81-87.
29. Silagi S. Control of pigment production in mouse melanoma cells in vitro. J Cell Biol 1969; 43:263-274.
30. Abdel-Malek ZA, Kreutzfeld KL, Hadley MD, et al. Long-term and residual melanotropin-stimulated tyrosinase activity in S91 melanoma cells is density dependent. In Vitro Cell Dev Biol 1986; 22:75-81.
31. Reenstra WE, Yaar M, Gilchrest BA. Effect of donor age on epidermal growth factor processing in man. Exp Cell Res 1993; 209:118-122.
32. Gordon L, Peacocke M, Gilchrest BA. Induction of c-fos but not c-myc in S-91 cells by melanization signals. J Dermatol Sci 1992; 3:35-41.
33. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann Biochem 1976; 72:248-254.
34. Liscovitch M, Cantly LC. Lipid second messengers. Cell 1994; 77:329-334.
35. Naeyaert JM, Eller M, Park HY, Gilchrest BA. Pigment content of cultured human melanocytes does not correlate with tyrosinase message level. Br J Dermatol 1991; 125:297-303.
36. Yamanish DT, Graham M, Buckmeier JA, Meyskens FL Jr. The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas. Carcinogenesis 1991; 42:105-109.
37. Veronesi U, Cascinelli N, Santinami M. Cutaneous melanoma: status of knowledge and future perspective. New York: Academic Press, 1987.
38. Hoganson GE, Ledwitz-Rigby F, Davidson RL, Fuller BB. Regulation of tyrosinase mRNA levels in mouse melanoma cell clones by melanocyte-stimulating hormone and cyclic AMP. Somat Cell Mol Genet 1989; 15:255-263.
39. Bitensky MW, Demopoulos MB, Russell V. Pigmentation: its genesis and biological control. Riley V, ed. New York: Appleton-Century-Crofts, 1972:247-255.
40. Deschatrette J, Weiss MC. Characterization of differentiated and dedifferentiated clones of a rat hepatoma. Biochimie 1974; 56:1603-1611.
41. Kuo CJ, Conley L, Chen FM, et al. A transcriptional hierarchy involved in cell-type specification is selectively inhibited by extinguishing lock. Nature 1992; 335:457-461.
42. Edelman AM, Blumenthal DK, Krebs EG. Protein serine/threonine kinases. Annu Rev Biochem 1987; 56:567-613.
43. Svoboda KKH. Intracellular localization of types I and II collagen mRNA and endoplasmic reticulum in embryonic corneal epithelia. J Cell Science 1991; 100:23-33.